Chapter 6: The Red Clause
[Wakefield & Gould, Don's Office — June 15, 2011, 3:00 PM]
The Haverford Chemical supplier agreement was one hundred and twelve pages long. Don had read it twice — once at normal speed, marking sections, and once with the Library running at a low burn that cost him a steady trickle of points but generated tags on every page. The first reading had taken two hours. The second took forty minutes, the Library accelerating his comprehension by connecting clauses to precedents to related cases in a web of associations that would have taken a team of paralegals a week to assemble manually.
Page forty-seven was where the problem lived.
Section 9.3(b) — Limitation of Liability. Buried in a thicket of boilerplate language that read like it had been copied from a template and never reviewed by anyone who cared about the person signing on the dotted line. The clause capped Haverford Chemical's liability for product defects at one hundred thousand dollars. For a pharmaceutical supply company whose chemicals went into drugs consumed by millions of people, that cap was less a legal protection and more a permission slip. If a contaminated batch reached market, MediTech would absorb virtually all the financial damage while Haverford walked away from the table for the price of a midrange sedan.
The Library had flagged it red on first contact. Not because the clause was unusual — liability caps were standard in supply contracts — but because the specific language deviated from standard formatting. The template wording would have read "aggregate liability." Haverford's version read "per-incident liability." The difference between those two phrases was the difference between a hundred-thousand-dollar total cap and a hundred-thousand-dollar cap per event, which sounded better until you realized it meant Haverford could cause multiple incidents and never exceed the per-event maximum.
Someone had changed the language. Deliberately. And either PH's reviewing attorney hadn't caught it or hadn't understood the implication.
Don followed the Library's tag chain. Step one: #liability-limitation. Step two: #per-incident-vs-aggregate. Step three: #unconscionability-pharmaceutical. Each step cost half a point — the Library dimming fractionally, the brightness behind his eyes dropping from a steady glow to a flicker. Three steps, one and a half LP. The chain terminated at a 2009 Second Department appellate decision: Brennan Medical Supply v. ChemCorp International. The ruling held that per-incident liability caps in pharmaceutical supply contracts could be voided as unconscionable if the supplier had superior bargaining position at the time of execution.
Don read the decision twice. The Library couldn't retrieve the full text — it wasn't advanced enough for that yet — but the tags gave him the case name, the court, the year, and the core holding. Enough to pull the actual document from Westlaw and build an argument around it.
He leaned back. The headache was mild — Library strain, not absorption or detection. Manageable. The kind of price he'd learned to budget for.
The question was how to present this to Kemp.
---
The answer, Don decided, was carefully.
Diane Kemp didn't know that her new attorney had identified the liability clause in forty minutes using a supernatural legal search engine. She believed she'd hired a diligent contract analyst from a respectable mid-tier firm. If Don walked into their meeting and produced the finding too quickly — if the gap between "received the file" and "found the needle in the haystack" was too narrow — Kemp might be impressed, but she'd also be suspicious. People didn't trust gifts that came too easily. They trusted work.
So Don built a trail.
He printed four cases from Westlaw — Brennan Medical and three related decisions that supported the unconscionability argument. He spread them across his desk in a pattern that suggested hours of manual research: highlighted passages, margin notes, sticky tabs on key pages. He drafted a two-page memo summarizing the issue, wrote it in the measured prose of a lawyer who'd arrived at his conclusion through methodical investigation, and included a "research timeline" that showed three days of progressive discovery rather than a single afternoon of Library-assisted revelation.
The performance made something twist behind his ribs. A small, sharp sensation — not guilt, exactly, but awareness. Awareness that he was staging a scene. That every interaction with every person in this world required a layer of theater between what he actually did and what he pretended to have done.
The cost of secrets. Not measurable in LP.
---
Kemp arrived at four-thirty. Her handshake was the same as before — efficient, communicative, no-nonsense. She sat across from Don's desk and he slid the memo toward her.
"I found something in the Haverford agreement," Don said. "Page forty-seven, Section 9.3(b). Liability limitation clause."
Kemp picked up the memo. Her eyes moved quickly — she read the way corporate officers read, scanning for the conclusion before deciding whether the analysis deserved attention. Don watched the detection register her response in real-time: a spike of heat when she reached the paragraph about per-incident versus aggregate language, followed by a deeper, slower burn as the implication settled.
"This caps their exposure at a hundred thousand per incident," Kemp said. Her voice was level. Her jaw was not.
"Per incident, not aggregate. The standard template uses aggregate language. Someone changed it."
"PH reviewed this contract."
"They did."
Kemp set the memo down. The detection registered something Don had learned to recognize over the past three months: the specific frequency of anger that comes from betrayal of professional trust. Not the hot, reactive anger of a personal insult. The cold, structural anger of a woman who'd paid premium rates for premium legal work and received something that could have destroyed her company if the wrong batch of chemicals had reached the wrong production line.
"How did Pearson Hardman miss this?" Kemp asked.
Don had an answer for that. The truthful answer was: because PH's pharmaceutical contract team was understaffed and over-leveraged, a systemic weakness he'd learned about from nine seasons of watching the show's background details. The answer he gave was different.
"Liability caps in supplier agreements are often reviewed by junior associates using standardized checklists. If the checklist asks 'Is there a liability limitation?' and the answer is yes, the box gets checked. The specific language — per-incident versus aggregate — requires a closer read than a checklist provides."
Kemp nodded. The anger didn't dissipate, but it redirected — away from Don, toward the firm that had failed her.
"Can we void it?"
"I found a Second Department ruling from 2009 — Brennan Medical Supply v. ChemCorp. The court held that per-incident caps in pharmaceutical supply contracts can be voided as unconscionable under certain conditions. Haverford had superior bargaining position when this contract was signed. MediTech was a smaller company in 2009 — you needed the supply relationship more than they needed you."
"That's changed."
"Exactly. Which gives us leverage for renegotiation and a legal basis if they refuse."
Kemp picked up the Brennan Medical printout. Scanned it. Set it down. Looked at Don with an expression he'd seen before on Wakefield's face after the Marsh deposition — the recalibration of expectations, the moment when someone realizes the person across from them is operating at a level they hadn't anticipated.
"I want aggressive renegotiation," Kemp said. "New terms. Aggregate liability, minimum two million cap, and a right-to-audit clause on their quality control."
"I'll draft the opening position tonight."
Kemp stood. Shook his hand again — longer this time, firmer. "PH had this contract for eight months, Mr. Klein. Eight months and three attorneys."
She didn't finish the sentence. She didn't need to. The implication sat between them like a verdict.
After Kemp left, Don sat at his desk and let the stillness settle. The Library was dim — tag chain costs adding up, the fog thicker than it had been this morning. He'd need a win to replenish. The MediTech renegotiation itself wouldn't count until it was resolved, but the work was solid. The argument was sound. The client was committed.
He allowed himself thirty seconds of satisfaction. The specific pleasure of having done something well — not through the Library alone, not through meta-knowledge alone, but through the combination of supernatural advantage and genuine legal skill that was becoming his operating mode. The Library found the clause. Don built the argument. Both were necessary. Neither was sufficient alone.
Thirty seconds. Then back to work.
He was reaching for the Haverford contract when something caught his eye. The memo from PH's original engagement file — the one Kemp had provided during onboarding — included a courtesy copy distribution list on the final page. Standard practice: everyone who'd been copied on the original client intake.
Three names. The reviewing attorney. The supervising partner. And at the bottom, in smaller type: cc: D. Paulsen, Legal Secretary, Senior Partner Division.
Donna.
Don stared at the name. Donna Paulsen processed PH's senior partner client intake. Which meant she tracked which clients came in, which stayed, and which left. She was the firm's institutional memory — the person who noticed patterns before the partners noticed them, who flagged anomalies before they became problems, who kept the machinery running while the name partners fought their wars.
MediTech's quarterly check-in was scheduled for July. When it came due and PH reached out, they'd find an empty chair. The client had moved. And Donna Paulsen would be the first person to ask why.
Don pinned the distribution list to his corkboard, next to the four-name client targeting card from two weeks ago.
He picked up his pen and wrote below Donna's name: She'll notice.
Two words. A warning to himself. A reminder that in a world where the most dangerous person wasn't the managing partner or the best closer or the brilliant fraud, but the legal secretary who knew everything and forgot nothing, every move left a footprint.
The MediTech file sat on his desk. The renegotiation draft needed writing. Haverford Chemical's response would come within two weeks, and when it did, the supplier would need legal representation of their own.
Don opened a blank document on his laptop and began typing the opening position. Outside, Manhattan was doing what Manhattan always did — compressing eight million lives into twenty-three square miles of noise and ambition and the peculiar energy of a city that treated every day like a negotiation.
His phone buzzed. Email notification. Don glanced at it.
From: Diane Kemp, MediTech Solutions. Subject: FW: Haverford Response — Preliminary
The email contained a forwarded message from Haverford Chemical's general counsel. The supplier had received MediTech's notice of contract review and was engaging outside representation for the renegotiation proceedings.
Their chosen firm: Pearson Hardman LLP.
Don read the name twice. Then he closed the email. Sat back. Let his breath out slowly.
Pearson Hardman. The firm he was stealing clients from had just been hired to defend a supplier against the very contract argument he'd built. He'd be sitting across the table from PH's litigation team. They'd see his name on the filings. They'd see his face in the negotiation room. The quiet junior associate from the quiet mid-tier firm, suddenly occupying the opposite chair in a dispute that their own negligence had created.
The Library flickered — a brief brightening, as if the machine recognized what was coming. Tags began forming, unprompted: #adversarial-proceeding. #conflict-of-interest-check. #opposing-counsel-assessment.
Don closed his eyes. Opened them.
Okay, he thought. Okay. So it starts here.
He picked up the phone and dialed Wakefield's extension.
"Martin. We need to talk about MediTech. Their supplier just lawyered up."
Author's Note / Promotion:
Your Reviews and Power Stones are the best way to show support. They help me know what you're enjoying and bring in new readers!
You don't have to. Get instant access to more content by supporting me on Patreon. I have three options so you can pick how far ahead you want to be:
🪙 Silver Tier ($6): Read 10 chapters ahead of the public site.
👑 Gold Tier ($9): Get 15-20 chapters ahead of the public site.
💎 Platinum Tier ($15): The ultimate experience. Get new chapters the second I finish them . No waiting for weekly drops, just pure, instant access.
Your support helps me write more .
👉 Find it all at patreon.com/fanficwriter1